Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas EBIT Margin 2010-2025 | HYPMY

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Hypermarcas (HYPMY) over the last 10 years. The current EBIT profit margin for Hypermarcas as of March 31, 2025 is .
  
Hypermarcas EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2025-03-31 $1.20B $0.18B 15.23%
2024-12-31 $1.38B $0.34B 24.51%
2024-09-30 $1.50B $0.44B 29.27%
2024-06-30 $1.60B $0.50B 31.45%
2024-03-31 $1.63B $0.52B 31.82%
2023-12-31 $1.59B $0.50B 31.78%
2023-09-30 $1.62B $0.53B 32.88%
2023-06-30 $1.57B $0.51B 32.65%
2023-03-31 $1.50B $0.50B 32.96%
2022-12-31 $1.46B $0.48B 32.99%
2022-09-30 $1.35B $0.45B 33.09%
2022-06-30 $1.27B $0.42B 33.02%
2022-03-31 $1.17B $0.40B 33.70%
2021-12-31 $1.10B $0.37B 33.27%
2021-09-30 $1.02B $0.33B 32.58%
2021-06-30 $0.91B $0.30B 32.42%
2021-03-31 $0.82B $0.27B 32.52%
2020-12-31 $0.79B $0.26B 32.24%
2020-09-30 $0.81B $0.24B 29.40%
2020-06-30 $0.87B $0.24B 27.63%
2020-03-31 $0.92B $0.23B 24.54%
2019-12-31 $0.84B $0.28B 32.93%
2019-09-30 $0.84B $0.31B 36.39%
2019-06-30 $0.83B $0.31B 36.88%
2019-03-31 $0.84B $0.33B 39.40%
2018-12-31 $1.02B $0.34B 32.97%
2018-09-30 $1.06B $0.34B 31.89%
2018-06-30 $1.12B $0.36B 31.94%
2018-03-31 $1.13B $0.36B 32.18%
2017-12-31 $1.14B $0.36B 31.93%
2017-09-30 $1.11B $0.36B 32.43%
2017-06-30 $1.06B $0.35B 32.80%
2017-03-31 $1.03B $0.34B 32.88%
2016-12-31 $0.94B $0.31B 32.56%
2016-09-30 $0.39B $0.28B 71.50%
2016-06-30 $0.52B $0.27B 52.60%
2016-03-31 $0.70B $0.24B 34.24%
2015-12-31 $0.90B $0.27B 29.90%
2015-09-30 $1.72B $0.29B 17.08%
2015-06-30 $1.82B $0.29B 15.81%
2015-03-31 $1.92B $0.35B 18.17%
2014-12-31 $1.97B $0.36B 18.30%
2014-09-30 $1.96B $0.41B 20.78%
2014-06-30 $1.99B $0.46B 23.24%
2014-03-31 $1.95B $0.41B 21.01%
2013-12-31 $1.95B $0.39B 19.73%
2013-09-30 $1.98B $0.41B 20.53%
2013-06-30 $1.97B $0.39B 19.92%
2013-03-31 $1.98B $0.42B 21.27%
2012-12-31 $1.96B $0.36B 18.51%
2012-09-30 $1.78B $0.29B 16.23%
2012-06-30 $1.84B $0.22B 11.88%
2012-03-31 $1.96B $0.21B 10.48%
2011-12-31 $2.00B $0.25B 12.66%
2011-09-30 $2.21B $0.29B 13.16%
2011-06-30 $2.12B $0.35B 16.29%
2011-03-31 $1.96B $0.33B 16.74%
2010-12-31 $1.81B $0.32B 17.49%
2010-09-30 $1.65B $0.26B 15.62%
2010-06-30 $1.44B $0.24B 16.53%
2010-03-31 $1.22B $0.24B 19.22%
2009-12-31 $1.03B $0.20B 19.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.958B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $75.757B 28.27
Takeda Pharmaceutical (TAK) Japan $47.602B 9.47
Daiichi Sankyo, - (DSNKY) Japan $46.162B 23.49
Sandoz Group AG (SDZNY) Switzerland $23.544B 0.00
Merck (MKKGY) Germany $16.989B 12.45
Summit Therapeutics (SMMT) United States $15.291B 0.00
United Therapeutics (UTHR) United States $14.697B 13.00
Shionogi (SGIOY) Japan $14.292B 14.32
Neurocrine Biosciences (NBIX) United States $12.409B 42.51
IPSEN (IPSEY) France $10.165B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.381B 60.00
Stevanato Group S.p.A (STVN) Italy $7.189B 43.96
Madrigal Pharmaceuticals (MDGL) United States $6.178B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.617B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.913B 14.94
Soleno Therapeutics (SLNO) United States $3.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.155B 11.06
Crinetics Pharmaceuticals (CRNX) United States $3.091B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.388B 12.92
BioCryst Pharmaceuticals (BCRX) United States $2.310B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.261B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
Indivior (INDV) United States $1.940B 8.23
Dyne Therapeutics (DYN) United States $1.671B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.592B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Ocular Therapeutix (OCUL) United States $1.437B 0.00
ARS Pharmaceuticals (SPRY) United States $1.423B 0.00
Guardian Pharmacy Services (GRDN) United States $1.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 22.14
Harrow (HROW) United States $1.086B 0.00
Akebia Therapeutics (AKBA) United States $1.043B 0.00
Enliven Therapeutics (ELVN) United States $1.018B 0.00
Collegium Pharmaceutical (COLL) United States $0.970B 5.23
Avadel Pharmaceuticals (AVDL) Ireland $0.940B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.714B 0.00
Xencor (XNCR) United States $0.687B 0.00
Liminatus Pharma (LIMN) United States $0.630B 0.00
Elite Pharmaceuticals (ELTP) United States $0.620B 0.00
AleAnna (ANNA) United States $0.617B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.563B 0.00
Verve Therapeutics (VERV) United States $0.552B 0.00
Bioventus (BVS) United States $0.550B 13.94
USANA Health Sciences (USNA) United States $0.547B 11.89
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Tourmaline Bio (TRML) United States $0.495B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Altimmune (ALT) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.431B 9.00
Savara (SVRA) United States $0.422B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 10.38
Aquestive Therapeutics (AQST) United States $0.354B 0.00
Heron Therapeutics (HRTX) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.298B 0.00
ProKidney (PROK) United States $0.286B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.59
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.233B 0.00
Nanobiotix S.A (NBTX) France $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.189B 0.00
OmniAb (OABI) United States $0.183B 0.00
Journey Medical (DERM) United States $0.172B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Avita Medical (RCEL) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.137B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Wellgistics Health (WGRX) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.098B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.095B 15.66
VAXART, INC (VXRT) United States $0.093B 0.00
Inotiv (NOTV) United States $0.092B 0.00
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.67
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
GlycoMimetics (GLYC) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00